House Hearing on the Sackler Family and the Opioid Epidemic
The House Oversight and Reform Committee held a hearing on the Sackler family’s role in the U.S. opioid crisis. The Sacklers own Purdue… read more
The House Oversight and Reform Committee held a hearing on the Sackler family’s role in the U.S. opioid crisis. The Sacklers own Purdue Pharma, which produced and marketed the highly addictive opioid Oxycontin. The attorneys general from Massachusetts and Idaho testified about the need for Congress to close a bankruptcy law loophole that would allow the Sacklers to avoid future liability against lawsuits and protect their personal wealth. Republicans argued about the importance of addressing the flow of illegal drugs coming into the United States across the southern border from Mexico. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Patrick Radden Keefe Author
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Hosting Organization
Related Video
-
AbbVie Pharmaceutical CEO Testimony on Prescription Drug Pricing
Richard Gonzalez, CEO of AbbVie, testified before the House Oversight and Reform Committee on drug prices for two of the company’s…
-
House Hearing on Purdue Pharma and the Opioid Epidemic
Top executives of Purdue Pharma, a U.S. pharmaceutical company that makes OxyContin, testified about their role in the opioid…
-
Pharmaceutical Executives Testimony on Drug Pricing, Day 2
Amgen CEO Robert Bradway, Novartis U.S. Country President Thomas Kendris, and Mallinckrodt Pharmaceuticals CEO Mark…
-
Pharmaceutical Executives Testimony on Drug Pricing, Day 1
Bristol-Myers Squibb CEO Dr. Giovanni Caforio, Teva CEO Kare Schultz and former Celgene CEO Mark Alles testified on…